NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 2, 2003, Pages 607-613

  Jacobs, Thomas ^a   Bruhn, Heike ^b   Gaworski, Iris ^a   Fleischer, Bernhard ^a   Leippe, Matthias ^b  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; MELITTIN; NK 2 PEPTIDE; NK LYSIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG ACTIVITY; DRUG POTENCY; ENZYME RELEASE; GLIOBLASTOMA; HOST CELL; INHIBITION KINETICS; MEMBRANE PERMEABILITY; MICROBIAL KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; PEPTIDES; PROTEOLIPIDS; PULMONARY SURFACTANTS; TRYPANOSOMA CRUZI;

EID: 0037308713     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.2.607-613.2003     Document Type: Article

References (37)

1. Amino, R., R. M. Martins, J. Procopio, I. Y. Hirata, M. A. Juliano, and S. Schenkman. 2002. Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis. J. Biol. Chem. 277: 6207-6213.
2. Andersson, M., H. Gunne, B. Agerberth, A. Boman, T. Bergman, R. Sillard, H. Jornvall, V. Mutt, B. Olsson, H. Wigzell, A. Dagerlind, H. G. Boman, and G. H. Gudmundsson. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 14:1615-1625.
3. Andrä, J., and M. Leippe. 1999. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med. Microbiol. Immunol. 188:117-124.
4. Andreu, D., C. Carreno, C. Linde, H. G. Boman, and M. Andersson. 1999. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344:845-849.
5. Baumann, G., and P. Mueller. 1974. A molecular model of membrane excitability. J. Supramol. Struct. 2:538-557.
6. Bilzer, T., D. Stavrou, E. Dahme, E. Keiditsch, K. F. Bürring, A. P. Anzil, and W. Wechsler. 1991. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch. 418:281-293.
7. Bisaggio Rda., C., S. L. de Castro, H. S. Barbosa, A. Brandao Cde, and P. M. Persechini. 1997. Trypanosoma cruzi: resistance to the pore forming protein of cytotoxic lymphocytes-perforin. Exp. Parasitol. 86:144-154.
8. Buck, M. A., T. A. Olah, C. J. Weitzmann, and B. S. Cooperman. 1989. Protein estimation by the product of integrated peak area and flow rate. Anal. Biochem. 182:295-299.
9. Buckner, F. S., C. L. Verlinde, A. C. La Flamme, and W. C. Van Voorhis. 1996. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase. Antimicrob. Agents Chemother. 40:2592-2597.
10. Ernst, W. A., S. Thoma-Uszynski, R. Teitelbaum, C. Ko, D. A. Hanson, C. Clayberger, A. M. Krensky, M. Leippe, B. R. Bloom, T. Ganz, and R. L. Modlin. 2000. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165:7102-7108.
11. Feder, R., R. Nehushtai, and A. Mor. 2001. Affinity driven molecular transfer from erythrocyte membrane to target cells. Peptides 22:1683-1690.
12. Ghosh, J. K., D. Shaool, P. Guillaud, L. Ciceron, D. Mazier, I. Kustanovich, Y. Shai, and A. Mor. 1997. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J. Biol. Chem. 272:31609-31616.
13. Jaynes, J. M., C. A. Burton, S. B. Barr, G. W. Jeffers, G. R. Julian, K. L. White, F. M. Enright, T. R. Klei, and R. A. Laine. 1988. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J. 2:2878-2883.
14. Krensky, A. M. 2000. Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem. Pharmacol. 59:317-320.
15. Krugliak, M., R. Feder, V. Y. Zolotarev, L. Gaidukov, A. Dagan, H. Ginsburg, and A. Mor. 2000. Antimalarial activities of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 44:2442-2451.
16. Kumar, J., S. Okada, C. Clayberger, and A. M. Krensky. 2001. Granulysin: a novel antimicrobial. Expert Opin. Investig. Drugs 10:321-329.
17. + T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 20:207-216.
18. Lehrer, R. I., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:23-27.
19. Ludtke, S. J., K. He, W. T. Heller, T. A. Harroun, L. Yang, and H. W. Huang. 1996. Membrane pores induced by magainin. Biochemistry 35:13723-13728.
20. Mai, J. C., H. Shen, S. C. Watkins, T. Cheng, and P. D. Robbins. 2002. Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J. Biol. Chem. 277:30208-30218.
21. Marr, J. J., and R. Docampo. 1986. Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research. Rev. Infect. Dis. 8:884-903.
22. + T cell-mediated protective immunity against Trypanosoma cruzi. Int. Immunol. 11:133-141.
23. Munford, R. S., P. O. Sheppard, and P. J. O'Hara. 1995. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 36:1653-1663.
24. Nickell, S. P., and D. Sharma. 2000. Trypanosoma cruzi: roles for perforindependent and perforin-independent immune mechanisms in acute resistance. Exp. Parasitol. 94:207-216.
25. Oren, Z., and Y. Shai. 1998, Mode of action of linear amphipathic alphahelical antimicrobial peptides. Biopolymers 47:451-463.
26. Pena, S. V., D. A. Hanson, B. A. Carr, T. J. Goralski, and A. M. Krensky. 1997. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158:2680-2688.
27. Prata, A. 2001. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect. Dis. 1:92-100.
28. Qi, X., and G. A. Grabowski. 2001. Differential membrane interactions of saposins A and C: implications for the functional specificity. J. Biol. Chem. 276:27010-27017.
29. Rivera-Vanderpas, M. T., A. M. Rodriguez, D. Afchain, H. Bazin, and A. Capron. 1983. Trypanosoma cruzi: variation in susceptibility of inbred strains of rats. Acta Trop. 40:5-10.
30. Rodrigues, M. M., M. Ribeirao, V. Pereira-Chioccola, L. Renia, and F. Costa. 1999. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67:3855-3863.
31. Shai, Y. 2002. From innate immunity to de-novo designed antimicrobial peptides. Curr. Pharm. Des. 8:715-725.
32. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125.
33. Tyler, K. M., and D. M. Engman. 2001. The life cycle of Trypanosoma cruzi revisited. Int. J. Parasitol. 31:472-481.
34. Viotti, R., C. Vigliano, H. Armenti, and E. Segura. 1994. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 127:151-162.
35. Wang, Z., E. Choice, A. Kaspar, D. Hanson, S. Okada, S. C. Lyu, A. M. Krensky, and C. Clayberger. 2000. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin, J. Immunol. 165:1486-1490.
36. Yang, L., T. A. Harroun, T. M. Weiss, L. Ding, and H. W. Huang. 2001. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 81:1475-1485.
37. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.